Elthera Awarded 2.5 M € Grant From Horizon 2020 Program ZURICH, June 17, 2019 /PRNewswire/ -- Elthera is pleased to announce that it has been awarded 2.5 M € through the Horizon 2020 programme. Horizon 2020 is the financial instrument implementing the Innovation Union, a Europe 2020 flagship initiative, [...]
Meet Elthera at: BIO June 03 – 6, 2019 in Philadelphia More Info
Meet Elthera at: ASCO May 31 – June 04, 2019 in Chicago
Meet Elthera at: Swiss Biotech Day May 07 in Basel
Elthera is joining Swiss National Startup Team Life Sciences 2018 ELTHERA has been selected by venturelab to become the next Venture Leaders Life Sciences 2018, chosen from among the most promising Life Sciences startups in Switzerland and to join the Swiss National Startup Team Life Sciences 2018 going to Boston [...]
Elthera Announces Positive Preclinical Proof of Concept (POC) Studies and Start of New Financing SCHLIEREN, Switzerland, March 19, 2018 ---Elthera is pleased to announce that it has demonstrated efficacy of its proprietary antibodies in tumor bearing animals. Anne Schmidt, Elthera CEO said, “We are very encouraged by these results demonstrating [...]
February 2018 Elthera has been selected to be part of the Bilan «50 Swiss start-up in which to invest 2018»
Elthera wins 3rd prize at the EIT European Health Catapult The European Health Catapult is a European wide startup competition for early stage startups working in Medtech, Biotech and Digital Health. The participating startups are looking specifically for Seed and Series A investments. The European health Catapult provides investors in [...]